|
Volumn 10, Issue 8, 1997, Pages 462-469
|
Muscarinic receptor subtypes: Pharmacology and therapeutic potential
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 ETHYL 8 METHYL 2,8 DIAZASPIRO[4.5]DECANE 1,3 DIONE;
3 (2 DIETHYLAMINO 2 METHYLPROPYLAMINO) 6 PHENYL 5 PROPYLPYRIDAZINE;
4 DIPHENYLACETOXY 1 METHYLPIPERIDINE;
ADENYLATE CYCLASE;
ATROPINE;
CEVIMELINE;
GUANINE NUCLEOTIDE BINDING PROTEIN;
HIMBACINE;
METHOCTRAMINE;
MUSCARINIC AGENT;
MUSCARINIC RECEPTOR;
MUSCARINIC RECEPTOR BLOCKING AGENT;
OTENZEPAD;
PIRENZEPINE;
RECEPTOR SUBTYPE;
TELENZEPINE;
TIOTROPIUM BROMIDE;
TRIPITRAMINE;
VAMICAMIDE;
XANOMELINE;
ALZHEIMER DISEASE;
ASTHMA;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONSTIPATION;
DRUG DESIGN;
DRUG SELECTIVITY;
GLAUCOMA;
HEART ARRHYTHMIA;
HUMAN;
IRRITABLE COLON;
MYDRIASIS;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PAIN;
PARKINSON DISEASE;
PEPTIC ULCER;
RECEPTOR AFFINITY;
RECEPTOR GENE;
REVIEW;
TACHYCARDIA;
TRANSDERMAL DRUG ADMINISTRATION;
URGE INCONTINENCE;
XEROSTOMIA;
|
EID: 0030813706
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (11)
|
References (75)
|